Literature DB >> 8360022

Immunologic cross-reactivity in the pathogenesis of ocular onchocerciasis.

N M McKechnie1, G Braun, V Connor, S Kläger, D W Taylor, R A Alexander, C E Gilbert.   

Abstract

PURPOSE: Onchocerca volvulus, a filarial worm, is a major cause of infectious blindness and inflammatory eye disease. An autoimmune cause for ocular onchocerciasis has been suggested since the identification of a recombinant antigen of O. volvulus that shows immunologic cross-reactivity with a host ocular component of 44,000 M(r). The aim of this study was to establish the distribution of the cross-reactive antigens in both host tissues and the parasite, and to determine if significant autoantibody responses to the host antigen could be detected in infected persons.
METHODS: The tissue and organ distribution of the 44,000 M(r) antigen was determined by immunocytochemistry and Western blot analysis. Human autoantibody responses to the ocular antigen were demonstrated by Western blot analysis using sera collected from persons with onchocerciasis, with and without posterior segment pathology, Bancroftian filariasis, and Europeans with no filarial infection.
RESULTS: The tissue distribution of the 44,000 M(r) antigen correlates with the sites of pathology in onchocerciasis and antibody reactivity against this antigen could be detected in all persons with onchocerciasis and posterior segment pathology. The antigen is also recognized by sera from persons with Bancroftian filariasis, but not from normal persons.
CONCLUSIONS: A role is proposed for immunologic cross-reactivity in the pathogenesis of onchocerciasis and it is suggested that intraocular presentation of the cross-reactive parasite antigen by microfilariae is essential for the development of disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8360022

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  11 in total

Review 1.  Retinopathies associated with antiretinal antibodies.

Authors:  J J Hooks; M O Tso; B Detrick
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

2.  CD4(+), CD8(+), immunoglobulin status and ocular lesions among some onchocerciasis-infected rural Nigerians.

Authors:  O P G Nmorsi; N C D Ukwandu; O J Alabi-Eric; W Popoola; M Osita-Emina
Journal:  Parasitol Res       Date:  2007-01-06       Impact factor: 2.289

3.  Human antiretinal antibodies in toxoplasma retinochoroiditis.

Authors:  R M Whittle; G R Wallace; R A Whiston; D C Dumonde; M R Stanford
Journal:  Br J Ophthalmol       Date:  1998-09       Impact factor: 4.638

Review 4.  Pathogenesis of onchocercal keratitis (River blindness).

Authors:  L R Hall; E Pearlman
Journal:  Clin Microbiol Rev       Date:  1999-07       Impact factor: 26.132

5.  Calgranulin C has filariacidal and filariastatic activity.

Authors:  J D Gottsch; S W Eisinger; S H Liu; A L Scott
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

6.  Onchocerciasis in Ecuador: evolution of chorioretinopathy after amocarzine treatment.

Authors:  P J Cooper; R Proaño; C Beltran; M Anselmi; R H Guderian
Journal:  Br J Ophthalmol       Date:  1996-04       Impact factor: 4.638

7.  MRI findings in people with epilepsy and nodding syndrome in an area endemic for onchocerciasis: an observational study.

Authors:  A S Winkler; K Friedrich; S Velicheti; J Dharsee; R König; A Nassri; M Meindl; A Kidunda; T H Müller; L Jilek-Aall; W Matuja; T Gotwald; E Schmutzhard
Journal:  Afr Health Sci       Date:  2013-06       Impact factor: 0.927

Review 8.  Case-control studies on the relationship between onchocerciasis and epilepsy: systematic review and meta-analysis.

Authors:  Christoph Kaiser; Sébastien D S Pion; Michel Boussinesq
Journal:  PLoS Negl Trop Dis       Date:  2013-03-28

9.  River blindness: an old disease on the brink of elimination and control.

Authors:  Kevin L Winthrop; Joao M Furtado; Juan C Silva; Serge Resnikoff; Van C Lansingh
Journal:  J Glob Infect Dis       Date:  2011-04

10.  Molecular and immunological characterization of hr44, a human ocular component immunologically cross-reactive with antigen Ov39 of Onchocerca volvulus.

Authors:  G Braun; N M McKechnie; W Gürr
Journal:  J Exp Med       Date:  1995-10-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.